To validate our findings, we did immunohistochemistry labeling on HCC patient tissue sections and discovered that HSPA1A was greatly overexpressed in the liver of HCC patients, but PPARGC1A expression was dramatically reduced (Fig. 7D). The gene discussed is PPARGC1A; the disease is hepatocellular carcinoma.